Annual Long Term Debt
$166.10 M
+$4.64 M+2.88%
31 December 2023
Summary:
Pharming Group NV annual long term debt is currently $166.10 million, with the most recent change of +$4.64 million (+2.88%) on 31 December 2023. During the last 3 years, it has risen by +$8.15 million (+5.16%). PHAR annual long term debt is now at all-time high.PHAR Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$119.88 M
+$4.83 M+4.20%
30 September 2024
Summary:
Pharming Group NV quarterly long term debt is currently $119.88 million, with the most recent change of +$4.83 million (+4.20%) on 30 September 2024. Over the past year, it has dropped by -$38.58 million (-24.35%). PHAR quarterly long term debt is now -27.83% below its all-time high of $166.10 million, reached on 31 December 2023.PHAR Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.9% | -24.4% |
| 3 y3 years | +5.2% | -25.2% |
| 5 y5 years | +287.9% | +356.3% |
PHAR Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +5.5% | -27.8% | +321.6% |
| 5 y | 5 years | at high | +3294.8% | -27.8% | +2350.1% |
| alltime | all time | at high | >+9999.0% | -27.8% | >+9999.0% |
Pharming Group NV Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $119.88 M(+4.2%) |
| June 2024 | - | $115.05 M(+304.6%) |
| Mar 2024 | - | $28.44 M(-82.9%) |
| Dec 2023 | $166.10 M(+2.9%) | $166.10 M(+4.8%) |
| Sept 2023 | - | $158.47 M(-3.7%) |
| June 2023 | - | $164.48 M(-0.1%) |
| Mar 2023 | - | $164.65 M(+2.0%) |
| Dec 2022 | $161.46 M(+2.5%) | $161.46 M(+19.4%) |
| Sept 2022 | - | $135.23 M(-6.7%) |
| June 2022 | - | $144.88 M(-5.6%) |
| Mar 2022 | - | $153.46 M(-2.5%) |
| Dec 2021 | $157.46 M(-0.3%) | $157.46 M(-1.8%) |
| Sept 2021 | - | $160.27 M(-3.4%) |
| June 2021 | - | $165.84 M(+11.6%) |
| Mar 2021 | - | $148.65 M(-5.9%) |
| Dec 2020 | $157.96 M(+3128.2%) | $157.96 M(+4.9%) |
| Sept 2020 | - | $150.62 M(+5.2%) |
| June 2020 | - | $143.23 M(+3.4%) |
| Mar 2020 | - | $138.55 M(+2731.5%) |
| Dec 2019 | $4.89 M(-88.6%) | $4.89 M(-81.4%) |
| Sept 2019 | - | $26.27 M(-23.0%) |
| June 2019 | - | $34.12 M(-16.2%) |
| Mar 2019 | - | $40.70 M(-5.0%) |
| Dec 2018 | $42.82 M(-40.1%) | $42.82 M(-11.5%) |
| Sept 2018 | - | $48.36 M(-13.1%) |
| June 2018 | - | $55.62 M(-10.4%) |
| Mar 2018 | - | $62.10 M(-13.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $71.44 M(+65.7%) | $71.44 M(-14.6%) |
| Sept 2017 | - | $83.68 M(-7.6%) |
| June 2017 | - | $90.60 M(+148.2%) |
| Mar 2017 | - | $36.51 M(-15.3%) |
| Dec 2016 | $43.11 M(+214.1%) | $43.11 M(+310.0%) |
| Sept 2016 | - | $10.52 M(-8.6%) |
| June 2016 | - | $11.50 M(-8.7%) |
| Mar 2016 | - | $12.60 M(-8.2%) |
| Dec 2015 | $13.73 M(+1069.7%) | $13.73 M(-14.8%) |
| Sept 2015 | - | $16.11 M(+1504.6%) |
| June 2015 | - | $1.00 M(+1.5%) |
| Mar 2015 | - | $988.70 K(-15.7%) |
| Dec 2014 | $1.17 M(-29.6%) | $1.17 M(-14.0%) |
| Sept 2014 | - | $1.37 M(-15.9%) |
| June 2014 | - | $1.62 M(+3.7%) |
| Mar 2014 | - | $1.57 M(-6.1%) |
| Dec 2013 | $1.67 M(-35.7%) | $1.67 M(-34.8%) |
| Sept 2013 | - | $2.55 M(+5.6%) |
| June 2013 | - | $2.42 M(+3.5%) |
| Mar 2013 | - | $2.34 M(-9.8%) |
| Dec 2012 | $2.59 M(-9.7%) | $2.59 M(-5.0%) |
| Sept 2012 | - | $2.73 M(+1.2%) |
| Mar 2012 | - | $2.70 M(-6.0%) |
| Dec 2011 | $2.87 M(+6639.0%) | $2.87 M(+6639.0%) |
| Dec 2010 | $42.60 K(-99.9%) | $42.60 K |
| Dec 2008 | $52.57 M(-35.1%) | - |
| Dec 2007 | $80.96 M | - |
FAQ
- What is Pharming Group NV annual long term debt?
- What is the all time high annual long term debt for Pharming Group NV?
- What is Pharming Group NV annual long term debt year-on-year change?
- What is Pharming Group NV quarterly long term debt?
- What is the all time high quarterly long term debt for Pharming Group NV?
- What is Pharming Group NV quarterly long term debt year-on-year change?
What is Pharming Group NV annual long term debt?
The current annual long term debt of PHAR is $166.10 M
What is the all time high annual long term debt for Pharming Group NV?
Pharming Group NV all-time high annual long term debt is $166.10 M
What is Pharming Group NV annual long term debt year-on-year change?
Over the past year, PHAR annual long term debt has changed by +$4.64 M (+2.88%)
What is Pharming Group NV quarterly long term debt?
The current quarterly long term debt of PHAR is $119.88 M
What is the all time high quarterly long term debt for Pharming Group NV?
Pharming Group NV all-time high quarterly long term debt is $166.10 M
What is Pharming Group NV quarterly long term debt year-on-year change?
Over the past year, PHAR quarterly long term debt has changed by -$38.58 M (-24.35%)